In order to further investigate whether TIMP-1 played an essential role in the mechanism of combined AS and TMP treatment for ischemic stroke, siRNA technology was used to interfere with the TIMP-1 gene in OGD cell models. The gene discussed is TIMP1; the disease is ischemic stroke.